ArticleBMC pregnancy and childbirth2026
Seroprevalence of anti-Toxoplasma antibodies among hospitalized newborns and their mothers: associated factors and maternal awareness in a cross-sectional study in Yasuj, Iran.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundToxoplasma gondii is a major congenital parasitic pathogen that can be transmitted vertically and is associated with a wide spectrum of adverse fetal and neonatal outcomes. In Iran, data on concurrent maternal-neonatal serological assessments remain limited, particularly in hospital-based settings. Neonatal serology is often interpreted without parallel maternal data or contextual information on awareness and risk factors. This hospital-based cross-sectional study in Yasuj, southwestern Iran, aimed to determine the seroprevalence of anti-Toxoplasma IgG and IgM among hospitalized infants and their mothers and to investigate associated factors and maternal awareness.
methodsThis cross-sectional study was conducted on 224 mother-infant pairs who were admitted to the neonatal ward and NICU of Imam Sajjad Hospital, Yasuj, between March and October 2023. Demographic characteristics, behavioral factors, and maternal awareness were collected through a structured questionnaire. IgG and IgM antibodies were measured by ELISA as part of a seroepidemiological assessment of maternal-neonatal antibody profiles. The association between maternal IgG seropositivity and various variables was analyzed using chi-square tests and logistic regression.
resultsAmong the mothers, 54 (24.1%) tested positive for IgG (95% CI: 19.0-30.1), while only one tested positive for IgM (0.4%; 95% CI: 0.1-2.5). Among the 224 infants, 9 (4%) were seropositive for IgG (95% CI: 2.1-7.5), all of whom were born to IgG-positive mothers; no infants tested positive for IgM, and no serological findings were suggestive of congenital infection. Cat exposure was the only factor independently associated with IgG seropositivity (aOR = 2.14; p = 0.020). Other variables, including age, education, place of residence, and consumption of undercooked meat, did not show significant associations. Maternal awareness was very low; only 13% had heard of the disease, and knowledge of transmission routes, prevention methods, and fetal outcomes was 4%, 2%, and 6%, respectively.
conclusionsMaternal seropositivity was detected, whereas no infant showed serological evidence suggestive of congenital transmission at the time of testing. Cat contact was the only behavioral factor independently associated with seropositivity. Maternal awareness was limited, particularly regarding transmission routes, prevention, and potential fetal risks. Strengthening prenatal education and incorporating risk-based assessment into routine care may support preventive strategies.
Indexed as
Identifiers
42121106What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.